CIK 0001746466 · Non-accelerated filer<br>Smaller reporting company
Equillium, Inc.
Sign in to watch- Ticker
- EQ
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 821554746
- Phone
- (858) 412-5302
- Business address
- 2223 AVENIDA DE LA PLAYA, SUITE 105, LA JOLLA, CA, 92037
- 8-K/A Event Exhibits
- 8-K Event Other events
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Open-market sale Chief Financial Officer sold 8,000 shares at $3.18 ($25,440)
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Results of operations
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Regulation FD disclosure
- 8-K Event Executive or director change · Other events
- 8-K Event Material agreement · Acquisition or sale completed · New debt or obligation · Unregistered share sale · Regulation FD disclosure · Other events
- SC 13G Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 4 Grant or award Chief Financial Officer acquired 5,585 shares (grant or award)
- 4 Grant or award Chief Development Officer acquired 1,290 shares (grant or award)
- 4 Open-market sale Chief Financial Officer sold 5,000 shares at $5.08 ($25,402)
- 4 Open-market sale Sr. Vice President and COO sold 11,434 shares at $5.49 ($62,715)
- 10-Q Report Quarterly Report
Page 14 of 24 · 469 filings